Due to increase in earnings per share in the third quarter 2026, Embecta 's 12 Months dividend pay out ratio sequentially decreased to 31.08% in the third quarter 2026, unsurprisingly, as the Embecta earnings continue to rise, and the pay out ratio remains below EMBC's average, the question arises, if Embecta will increase the dividend soon.
Within Healthcare sector 28 other companies have achieved higher 12 Months dividend pay out ratio. While in terms of ranking among all other companies, the company has moved form 584 in the second quarter 2026, to 834.
A Financial Balancing Act: Embecta Declares Dividend Amid Financial Challenges and Diabetes AdvocacyIn a strategic move that illustrates both resilience and commitment, Embecta Corp. has declared a quarterly cash dividend of $0.15 per share for all issued and outstanding shares of its common stock. This announcement, made on February 6, 2025, underscores the company's dedication to providing shareholder returns, despite the financial and market challenges that have characterized the past year. The dividend, scheduled for payment on March 14, 2025, will benefit stockholders of record by the close of business on February 28, 2025. A Bold Decision Amidst Industry TurbulenceThis decision comes during a period of notable challenges and transitions for Embecta, a company that stands as one of the foremost players in the diabetes management industry. In the wake of a global economic landscape fraught with uncertainty, companies, particularly in the healthcare sector, have been grappling with a variety of issues. These range from navigating supply chain disruptions to managing rising costs and responding to regulatory changes. Despite these hurdles, Embecta's board has opted to maintain its consistent dividend payout, highlighting both fiduciary responsibility to shareholders and confidence in the company's long-term strategy.
Innovative Approaches Amid Financial Hurdles: Embecta Corp. Declares Quarterly Dividend and Rings Nasdaq Bell for Diabetes AwarenessIn a notable announcement from Embecta Corp., the New Jersey-based medical technology company has declared a quarterly cash dividend of $0.15 per share for its common stock, according to a press release dated November 26, 2024. This declaration underscores Embecta's commitment to delivering value to its shareholders, even as it perseveres through a challenging economic climate.The dividend is scheduled to be paid on December 18, 2024, to shareholders who are recorded as of the close of business on December 6, 2024. This persistent adherence to shareholder returns marks a significant move for a company operating under the financial pressures that characterize the current market landscape.
Embecta Corp. Boosts Shareholder Confidence with Quarterly Dividend Amid Strong Financial Performance Embecta Corp., a prominent player in the healthcare sector, recently announced a quarterly cash dividend of $0.15 per share, reflecting its ongoing commitment to delivering value to shareholders. The dividend, which will be payable on September 13, 2024, is aimed at stockholders of record as of the close of business on August 27, 2024. On the backdrop of a robust financial performance, the announcement of this dividend comes at a crucial time for Embecta. As of the writing of this article, the company has reported an increase in earnings per share (EPS) for the second quarter of 2024. This positive trend has allowed Embecta to achieve a noteworthy reduction in its 12-month dividend payout ratio, which sequentially decreased to 49% in the second quarter. This figure, while remaining above the sector average, indicates that the company is effectively managing its resources and maintaining healthy cash flows.
PARSIPPANY, N.J., May 09, 2024 - Embecta Corp. (embecta) (Nasdaq: EMBC) recently announced the declaration of a quarterly cash dividend amounting to $0.15 per share for each issued and outstanding share of the company's common stock. This development comes amidst a challenging period for Embecta Corp., as its share price has experienced a downward trend, ultimately resulting in a significant decline over the past 90 days. The impact of this news on shareholders, as well as the broader context of the company's recent performance, is worth exploring. Looking back at the previous news, released on date, the downward trajectory of Embecta Corp. shares was evident. Throughout the month of May, the shares recorded a decline of 0.99%, further worsening the overall performance and bringing the share price down by a staggering 40.87% over the past 90 days. Furthermore, at present, Embecta Corp. shares are trading a mere 3.1% above the company's 52-week low.
Embecta Corp Announces Record Quarterly Cash Dividend: A Look at the Company's Dividend Pay Out Ratio On February 9, 2024, Embecta Corp (Nasdaq: EMBC) made an exciting announcement regarding their quarterly cash dividend. The Board of Directors declared a dividend of $0.15 for each issued and outstanding share of the company's common stock, payable on March 15, 2024, to stockholders of record as of February 28, 2024. This news comes as Embecta Corp's 12 Months dividend pay out ratio has reached a new high in the fourth quarter of 2023, standing at 48.67. This demonstrates the company's commitment to providing value to its shareholders through consistent dividend payments.
Embecta Corp. Declares Quarterly Cash Dividend: An Encouraging Move for Shareholders PARSIPPANY, N.J., Nov. 21, 2023 - Embecta Corp. (Nasdaq: EMBC), a leading player in the technology industry, has announced its decision to declare a quarterly cash dividend of $0.15 for each issued and outstanding share of the company's common stock. The dividend payment provides a welcome boost to shareholders and showcases Embecta's commitment to rewarding its investors. This significant development was announced by Embecta's Board of Directors, who have recognized the company's solid financial performance and healthy cash flow. By distributing a portion of its earnings to shareholders in the form of a dividend, Embecta is providing an attractive incentive for investors and fostering confidence in the company's long-term prospects.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
